Breyna is used to treat asthma in patients aged 6 years old and older, and in the maintenance treatment of airflow obstruction and reducing exacerbations for patients with COPD.
Nystatin and Triamcinolone Acetonide are used for the treatment of cutaneous candidiasis, which is an infection of the skin and nails caused by the candida fungus.
Upon completion of the distribution, Embecta will be an independent and publicly traded company focused on diabetes management that BD will retain no ownership interest.